Suven Life Sciences Q1 FY22 earnings call: Revenue & Margins
Q1 FY22 investor presentation: what the company reported on revenue, margins and capex.
Top 10 Healthcare Services companies on management guidance
See the sector's top 10 — free with your mobile number.
Based on Suven Life Sciences Ltd's Q1 FY22 investor presentation. The company has not published an earnings-call transcript for this quarter, so figures here are what the investor presentation reports, not management guidance.
Revenue & Sales Performance
See what Suven Life Sciences Ltd said on revenue & sales performance — free account, 30 seconds.
Profitability & Margins
See what Suven Life Sciences Ltd said on profitability & margins — free account, 30 seconds.
Capital Expenditure Plans
Top-ranked in Healthcare Services
Ranked on what management guided this quarter
Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.
Fundraising & Capital Structure
See what Suven Life Sciences Ltd said on fundraising & capital structure — free account, 30 seconds.
Order Book & Pipeline
See what Suven Life Sciences Ltd said on order book & pipeline — free account, 30 seconds.
Suven Life Sciences Ltd — Quarterly revenue & net profit
Reported quarterly figures (₹ Cr). Latest (Q2 FY27): revenue ₹1 Cr, net loss ₹107 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.
Full financials →Continue your research
What Suven Life Sciences's management said in earlier quarters
Potential multibaggers · Q2 FY27
Potential multibaggers in Healthcare Services
on management's own guidance
- Strong growth2
- Strong growth1
- IndegeneGood growth3
Portfolio builder
Build your portfolio
from the top-ranked stocks
- 1. Pick 3–15 stocks
- 2. Choose large, mid or small cap and your sectors
- 3. Get a portfolio built from the rankings
Ranks describe management commentary on revenue and margin from the latest earnings call. Not investment advice.
Arthneeti Pro · Annual
Suven Life Sciences Ltd and 15K+ more earnings calls,
for less than your morning chai
Every earnings call, ranking and concall Q&A across all four results seasons.
Secure Razorpay payment · instant access
Frequently Asked Questions
What is Suven Life Sciences Ltd share price analysis?
Suven Life Sciences Ltd currently shows a neutral. The stock trades at a P/E of N/A with a market cap of ₹9,651 Cr. Investors should review the full earnings analysis for detailed insights.
Keep Suven Life Sciences Ltd on your radar — track it to get its next earnings analysis in your feed.
This analysis is AI-generated based on publicly available earnings data and the company's investor presentation. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.
